GLENMARK

Glenmark Pharmaceuticals Limited (GLENMARK)

NSE
INR 1830.42.63%

Price Chart

Key Statistics

Market Cap
INR 519.56B
P/E Ratio
49.52
Revenue (TTM)
INR 134.35B
Volume
814.81K
52W High
INR 1843.30
52W Low
INR 1275.50
Dividend Yield
0.14%
Beta
0.20

Technicals

50-Day MA
1537.272
200-Day MA
1524.3268
52 Week High
1843.3
52 Week Low
1275.5

About GLENMARK

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America.

Employees
N/A
Headquarters
Mumbai, India
CEO
Mr. Glenn Mario Saldanha

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg